Validation of the Brazilian Version of the Montreal Cognitive Assessment - Basic (MoCA-B) and Montreal Cognitive Assessment - Blind (MoCA-Blind) for Screening Cognitive Decline
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 124
- 主要终点
- Optimal cut-off score for the MoCA-B and MoCA-Blind
研究概览
简要总结
The objective of this observational study is to assess the efficacy of two neuropsychological tests (MoCA-B and MoCA-Blind) in detecting cognitive decline in older adults. The main questions it aims to answer are:
Can the results obtained by older adults on the MoCA-B distinguish between those with and without cognitive decline? Can the results obtained by older adults on the MoCA-Blind distinguish between those with and without cognitive decline?
Participants will be required to: 1. Complete a sociodemographic questionnaire; 2. Undergo a visual acuity test; 3. Complete the Pfeffer and IQCODE scales; and 4. Complete the MMSE, MoCA-B, and MoCA-Blind.
研究设计
- 研究类型
- 观察性
- 观察模型
- 病例对照
- 时间视角
- 横断面
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- Older adults aged 60 and over;
排除标准
- Participants under 60 years of age
- Participants with a prior neuropsychological, neurological, or psychiatric diagnosis that could negatively influence assessment results, such as schizophrenia, stroke within the last three months, intellectual disability, etc
- Participants with self-reported or diagnosed hearing impairment (hearing loss or deafness) that is not corrected by hearing aids.
研究组 & 干预措施
older adults with cognitive decline and without visual impairment
older adults without cognitive decline (healthy) and without visual impairment
older adults with cognitive decline and with visual impairment
older adults without cognitive decline and with visual impairment
结局指标
主要结局
Optimal cut-off score for the MoCA-B and MoCA-Blind
时间窗: Assessed at baseline (Day 0)
The scores obtained by the participants (0 to 30) will be used to calculate the ROC curve and determine the optimal cutoff point (highest sensitivity and specificity) to distinguish between cognitive decline and healthy individuals.
次要结局
未报告次要终点
研究者
标识符
- NCT 编号
- NCT07846839
- 其他研究编号
- 01815126.6.1001.5537
日期
- 首次提交
- (14天前)
- 首次发布
- (昨天)
- 主要完成日期
- (5个月后)
- 研究完成日期
- (5个月后)
- 最近核实
- (29天前)
- 最近更新
- (昨天)
监管与共享
- FDA 监管药物
- 否
- FDA 监管器械
- 否
- 个体参与者数据共享计划
- 否
- 是否有结果
- 否